Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics.
about
Intestinal permeability in children/adolescents with functional dyspepsia.Cysteinyl leukotrienes acting via granule membrane-expressed receptors elicit secretion from within cell-free human eosinophil granules.Analysis of Gastric and Duodenal Eosinophils in Children with Abdominal Pain Related Functional Gastrointestinal Disorders According to Rome III CriteriaIncreased Duodenal Eosinophil Degranulation in Patients with Functional Dyspepsia: A Prospective StudyWomen and functional dyspepsiaTherapeutic strategies for the treatment of dyspepsia.The role of eosinophils and mast cells in intestinal functional disease.Eosinophils and mast cells as therapeutic targets in pediatric functional dyspepsiaEmerging drugs for functional dyspepsia.Immune dysregulation in the functional gastrointestinal disorders.Functional dyspepsia is associated with duodenal eosinophilia in an Australian paediatric cohort.The Gastric and Duodenal Eosinophilia in Functional Dyspepsia.Functional dyspepsia and duodenal eosinophilia: A new model.Editorial: functional dyspepsia-a disorder of duodenal permeability?Quantitative Analysis of Distribution of the Gastrointestinal Tract Eosinophils in Childhood Functional Abdominal Pain DisordersFunctional dyspepsiaFunctional dyspepsia
P2860
Q33617430-0F1393BF-116E-4C87-B611-F8FA4A4652DBQ33669090-27A6D39F-2F1E-4BDC-A750-4F64C5B7DB3FQ37058969-4690197E-C957-4145-A879-C2EBF5F9D1B2Q37314845-4089D256-16A5-4F38-B047-373E08F78D66Q37732178-1D15FA50-CF2A-4D4F-871B-FD2418005D72Q37781371-D977AD50-4706-4019-BD29-DFFCBF6DC8ADQ37873352-2A10F527-41EB-4315-A651-DDD64FAB5BBFQ38160491-39F88902-D78D-41F7-8345-639B8FB87BF8Q38342083-47C76E12-2A4B-4A51-B87B-C14F05DB25BFQ38601401-0025E4BE-4153-4D21-8BB6-8F57560070F9Q40281641-E1B8BBE9-3301-4CF5-BF76-105340160EDFQ42445738-04EF282D-6BBA-4C66-B411-88D40A9F3314Q47691689-1A3484F5-6146-4817-84B6-920FD1EF9B22Q48315936-F7C678AF-A1E0-4970-B322-CE2C1A92D3FAQ57098677-BDF401FD-E2EB-4CD2-8281-974EAFDDA9AEQ57653128-67C70D18-F8F1-4EE2-B49D-46EA936D3BAFQ57789296-94AAB5C5-B62E-4CE9-AAF7-6AB4657D6641
P2860
Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Montelukast in the treatment o ...... relation to pharmacokinetics.
@ast
Montelukast in the treatment o ...... relation to pharmacokinetics.
@en
type
label
Montelukast in the treatment o ...... relation to pharmacokinetics.
@ast
Montelukast in the treatment o ...... relation to pharmacokinetics.
@en
prefLabel
Montelukast in the treatment o ...... relation to pharmacokinetics.
@ast
Montelukast in the treatment o ...... relation to pharmacokinetics.
@en
P2093
P2860
P356
P1433
P1476
Montelukast in the treatment o ...... relation to pharmacokinetics.
@en
P2093
Craig A Friesen
Debra L Taylor
Gregory L Kearns
Nancy A Neilan
Susan M Abdel-Rahman
P2860
P2888
P356
10.1186/1471-230X-9-32
P577
2009-05-11T00:00:00Z
P6179
1050799682